Foren & Soziale Netzwerke zur JOHNSON & JOHNSON Aktie

 

und neue Kursziele:https://seekingalpha.com/news/4639561-jj-stock-at-all-time-high-ubs-assumes-buy -Marygold

https://de.marketscreener.com/boerse-nachrichten/johnson-johnson-kuendigt-vergleich-ueber-5-5-mrd-usd-zu-talkum-klagen-an-ce7f51ddd98af122Johnson & Johnson kündigt Vergleich über 5,5 Mrd. USD in Talkum-Klagen anJohnson & Johnson teilte am Montag mit, dass das Unternehmen einen Vergleich über 5,5 Mrd. USD erzielt hat, der Zehntausende Klagen beilegen soll, ... -Tamakoschy

Konsolidierung nach starkem Lauf - wie geht es weiter? - Divantis

While many believe there is a convincing top on JNJ at the 251 zone, which would indicate a much more meaningful correction below the 200 zone, evidence suggests that the 251 zone is more likely to be a lower degree, and that support in the 208 - 215 zone should hold. That said, from that support, Elliott Wave guidelines would suggest we look for another five-wave structure to the upside, in what would be a larger degree extended wave five. I base this on the following evidence: -Elliott wave guidelines suggest there should be bearish divergence between wave 3 and 5, and we should look for that divergence on a fractile basis to support the count. Keep in mind that the higher the timeframe of divergence, the more confirmation provided. That said, there is a lack of bearish weekly divergence between the December 15th 2025, weekly high at 215, and the March 2nd 2026, weekly high at 251, which would suggest that the 251 high is more likely not a wave 5 top, and instead a wave 3 top. Therefore, we would be lookin

Kursziel: 226.2596 €

Kursziel: 232.7325 €

Kursziel: 208.1898 €

Kursziel: 218.9904 €

Kursziel: 223.2344 €

Kursziel: 233.42 €

https://de.marketscreener.com/boerse-nachrichten/johnson-johnson-hebt-prognose-fuer-2026-nach-uebertroffenen-erstquartalszahlen-an-ce7e50dfda80f227Johnson & Johnson hebt Prognose für 2026 nach übertroffenen Erstquartalszahlen an(MT Newswires) -- Johnson & Johnson (JNJ) hat am Dienstag seine Prognose für das Gesamtjahr angehoben, nachdem die Ergebnisse des ... -Tamakoschy

Dies ist ein automatisiert generierter Hinweis auf die neueste News zu "Johnson & Johnson Corp" aus der ARIVA.DE Redaktion.27 Schwergewichte legen Zahlen vor. Banken, Johnson & Johnson und Netflix müssen jetzt zeigen, wie sie mit Unsicherheit, Energiepreisen und nervösen Märkten umgehen. Darauf schaut die Wall Street ganz genau.Lesen Sie den ganzen Artikel: -ARIVA.DE

Johnson & Johnson ist für mich zum Stand 11. April 2026 ein sehr hochwertiges, aber keineswegs billiges Qualitätsunternehmen. Die Aktie schloss am 10. April 2026 in den USA bei 238,46 US-Dollar, also auf dem letzten vorliegenden Schlusskurs vor Deinem Stichtag. Bezogen auf das bereinigte ... -MrTrillion3

Kursziel: 228.3918 €

Kursziel: 214.2 €

Kursziel: 247.1805 €

Kursziel: 211.6212 €

✅ Chart Analysis 1. Demand Zone Rejection Price pulled back perfectly into a well‑defined demand zone — this is where buyers previously stepped in aggressively. The reaction confirms strong institutional demand. 2. Trendline Break + Retest A descending trendline was broken, and price successfully retested the trendline from above, turning previous resistance into new support. This is a classic continuation signal. 3. EMAs Supporting the Trend Price is trading above the 50‑day EMA, showing short‑term strength. The 200‑day EMA is trending upward, confirming long‑term bullish structure. 4. Volume Behavior During the dip into the demand zone, volume remained controlled — a sign of absorption instead of panic selling. 5. Stochastic Indicator Stochastics curled upward from lower levels, supporting a momentum continuation. ? Technical Bias: Bullish as long as price holds above the demand zone ✅ Trade Idea Entry zone: Inside the demand/support area Stop‑loss: Place the stop‑loss below the demand zone, or adjust

✅ Chart Analysis 1. Demand Zone Rejection Price pulled back perfectly into a well‑defined demand zone — this is where buyers previously stepped in aggressively. The reaction confirms strong institutional demand. 2. Trendline Break + Retest A descending trendline was broken, and price successfully retested the trendline from above, turning previous resistance into new support. This is a classic continuation signal. 3. EMAs Supporting the Trend Price is trading above the 50‑day EMA, showing short‑term strength. The 200‑day EMA is trending upward, confirming long‑term bullish structure. 4. Volume Behavior During the dip into the demand zone, volume remained controlled — a sign of absorption instead of panic selling. 5. Stochastic Indicator Stochastics curled upward from lower levels, supporting a momentum continuation. ? Technical Bias: Bullish as long as price holds above the demand zone ✅ Trade Idea Entry zone: Inside the demand/support area Stop‑loss: Place the stop‑loss below the demand zone, or adjust

Based on the recent pharma agreements reported by Reuters — where 16 global drugmakers committed to lower U.S. prices in exchange for tariff exemptions — overall sector sentiment appears stable. Technically, price is reacting well within the demand zone, retesting structure and holding above key moving averages. This improves the probability of upside continuation but does not eliminate risk, especially given that FactCheck.org notes the long‑term impact of these agreements is still uncertain.